Skip to main navigation
Skip to search
Skip to main content
Search by expertise, name or affiliation
SAHMRI Annual Scientific Meeting 2018
Acute Lymphoblastic Leukamia (ALL) Research Group
Tavakoli PS, Eadie LN, Heatley SL, White DL.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Adelaide, South Australia
25 Oct 2018
26 Oct 2018